Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Graft vs Host Disease 3Neoplasms 2Myelodysplastic Syndromes 2Leukemia 2Sezary Syndrome 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1Mycosis Fungoides 1Lymphoma, T-Cell, Cutaneous 1Lymphoma, Non-Hodgkin 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 1Leukemia, Myeloid 1Leukemia, Lymphoid 1Immunologic Deficiency Syndromes 1Hodgkin Disease 1Hemoglobinopathies 1Hematologic Neoplasms 1Bronchiolitis Obliterans Syndrome 1Anemia, Refractory, with Excess of Blasts 1Anemia, Refractory 1

Interventions

ibrutinib 5fludarabine 4Rituximab 4Lenalidomide 3Busulfan 3thymoglobulin 2fludarabine phosphate 2blinatumomab 2Vincristine 2Methotrexate 2Melphalan 2Bendamustine Hydrochloride 2Behavior Therapy 2Alemtuzumab 2tozasertib 1sargramostim 1romiplostim 1pirtobrutinib 1pegaspargase 1palbociclib 1ofatumumab 1obinutuzumab 1mocetinostat 1lirilumab 1forodesine 1fenebrutinib 1enzastaurin 1duvelisib 1Stem Cell Transplantation 1RFT5-SMPT-dgA immunotoxin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Leukemia, Lymphoid × Photopheresis × Clear all
NCT01174940 2017-01-09

Test Extracorporeal Photopheresis (ECP) Treatment Before/After Allogeneic Bone Marrow Transplant (BMT) or Peripheral Blood Stem Cell (PBSC) Transplant to Prevent Graft Versus Host Disease

University of Kansas Medical Center

Phase EARLY_PHASE1 Completed
22 enrolled
LymphoidMyeloidOther hematologic neoplasm

Graft vs Host Disease, Hodgkin Disease, Leukemia, Lymphoid, Leukemia, Myeloid, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡